Japanese encephalitis vaccine for travelers: exploring the limits of risk.
The prevention of Japanese encephalitis in travelers presents the juxtaposition of 4 factors: a disease that is widespread throughout Asia, a disease with a low incidence in travelers, a vaccine about which there are safety concerns, and a clinical course that can result in death or permanent disability in two-thirds of symptomatic cases. Travel medicine practitioners often seem to be polarized into 2 groups: a group that gives more weight to the severity of the disease (and therefore often recommend vaccination) and another group that is more persuaded by the low occurrence of cases in travelers (and therefore rarely recommend vaccination). This review assesses the known risks of contracting Japanese encephalitis and the risks associated with the vaccine and tries to develop an appropriate way to recommend this vaccine to travelers who may be at significant risk.
Shlim
David R
DR
Jackson Hole Travel and Tropical Medicine, Kelly, WY 83011, USA. drshlim@wyoming.com
Solomon
Tom
T
D001208:Asia / Q000453:epidemiology; D004664:Encephalitis Virus, Japanese / Q000276:immunology*; D004672:Encephalitis, Japanese / Q000453:epidemiology / Q000401:mortality / Q000517:prevention & control*; D006801:Humans; D022321:Japanese Encephalitis Vaccines / Q000009:adverse effects / Q000627:therapeutic use*; D012307:Risk Factors; D014195:Travel
D022321:Japanese Encephalitis Vaccines